Clinical trial Recruiting at 10 sites Interventional Ages 18 and up

Normothermic machine perfusion to re-evaluate declined donor livers and shorten transplant waiting time

Official title: Pilot, Open, Prospective, Randomized, Multicenter Trial On Quality Assessment Of Declined Liver Grafts By Normothermic Ex Vivo Machine Perfusion For Decreasing Time To Transplantation

Run by Charite University, Berlin, Germany · NCT06874296 · Data updated 2026-11-12

This trial tests whether keeping declined donor livers functioning on a normothermic perfusion machine can make more livers usable and help adults on the transplant waiting list (ReMELD‑Na ≤21) get transplanted sooner.

More Liver Transplantation trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment186 (estimated)
SponsorCharite University, Berlin, Germany
Academic / other
Locations10 sites (Hamburg, Free and Hanseatic City of Hamburg and 9 other locations)
StatusRecruiting
StartedJune 2, 2025
Main results expectedMay 31, 2029
Study endsDecember 31, 2030
Registry record updatedApril 15, 2026
Trial IDNCT06874296 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18) listed as transplantable at a participating center with ReMELD‑Na ≤21 (MELD ≤25), able to consent and medically suitable for transplantation with extended-criteria donor organs, who are not listed for retransplantation, high-urgency, or combined-organ transplant.

Probably not a fit

Patients listed for retransplantation, high-urgency or combined-organ transplants, pregnant patients, or those with higher MELD scores or special exception status are not eligible and would not benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled study enrolls adults listed for liver transplantation with a ReMELD‑Na score ≤21 who are not eligible for non-standard exceptions. Participants are randomized to standard organ offers or to a group that, in addition to standard offers, may be offered livers previously declined that are re-assessed using normothermic machine perfusion (NMP), which keeps the organ working outside the body for objective quality testing. The trial examines whether NMP-based reassessment increases organ utilization, shortens waiting time, and improves post-transplant survival and clinical outcomes compared with current practice. It is conducted at three major German transplant centers and is the first randomized study to test NMP reassessment of declined grafts in this patient population.

Why it matters

Potential benefit: If successful, more donor livers could be used and eligible patients could receive transplants sooner with potentially better outcomes.

How similar studies have gone: Non-randomized studies from the UK, Netherlands, Australia, and the USA have shown NMP can increase organ utilization, but randomized evidence testing reassessment of declined grafts has been lacking until this trial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Able to consent
* ≥ 18 years old
* Listed in status "transplantable" by the transplant conference of the study centre for liver transplantation, according to the guidelines of the German Medical Association valid at the time of inclusion
* ReMELD-Na-Score ≤ 21 (equivalent to MELD ≤25), not eligible for \[non\]standard exceptions
* Medically suitable and informed for transplantation with an organ that fulfils extended donor criteria (Eurotransplant ECD criteria)
* Patient information and written consent to participate in the Extra trial
* No participation in another interventional study during participation

Exclusion Criteria:

* Listed for retransplantation
* High-Urgency Listing
* Listed for combined organ transplantation
* Pregnancy

Where it's running

  • University Medical Center Hamburg-Eppendorf
    Hamburg, Free and Hanseatic City of Hamburg, Germany
    Recruiting
  • University Hospital RWTH Aachen
    Aachen, North Rhine-Westphalia, Germany
    Recruiting
  • University Hospital Bonn
    Bonn, North Rhine-Westphalia, Germany
    Recruiting
  • University Hospital Muenster
    Münster, North Rhine-Westphalia, Germany
    Recruiting
  • Department of Surgery Campus Charité Mitte | Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin
    Berlin, State of Berlin, Germany
    Recruiting
  • Department of General, Visceral and Transplant Surgery, Hannover Medical School
    Hanover, Germany
    Recruiting
Show 4 more locations
  • Department of General, Visceral and Transplantation Surgery, LMU University Hospital, LMU Munich
    München, Germany
    Recruiting
  • Department of Surgery, University Hospital Regensburg
    Regensburg, Germany
    Recruiting
  • Eberhard Karls University of Tübingen, Department of General Visceral and Transplant Surgery
    Tübingen, Germany
    Recruiting
  • Department of General, Visceral, Transplantation, Vascular, and Pediatric Surgery, University Hospital Wurzburg
    Würzburg, Germany
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.